Absci Corporation ABSI 深 滬
等待開盤 03-26 09:30:00 美东时间
2.92
-0.090
-2.99%
華盛通- 最 高3.11
- 今 開2.90
- 成交量 713.79万股
- 最 低 2.80
- 昨 收 3.01
- 總市值 4.38亿
- 52周最高 5.228
- 市盈率 靜 --
- 換手率 4.76%
- 52周最低 2.0105
- 委 比 -84.70%
- 總股本 1.50亿
- 歷史最高 31.53
- 量 比 1.30
- 振 幅 10.30%
- 歷史最低 1.1111
- 每 手 1
- 風險率 0.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多电话会总结 ｜ Absci(ABSI)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Absci业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2025年第四季度营收为70万美元，主要来源于合作项目的进展。 **费用支出：** - 研发费用为2,530万美元，主要用于内部项目推进，特别是ABS-101和ABS-201的临床前及临床开发 - 销售、一般及行政费用为860万美元 **现金状况：** 截至2025年12月31日，现金、现金等价物及有价证券总额为1.443亿美元 **其他收益：** 公司通过或有对价结算获得510万美元收益，产生870万美元无限制现金 ## 2. 财务指标变化 **营收变化
今天 12:30
美股夜盘 | Blaize Holdings, Inc.涨53.15%，中阳金融集团涨36.70%
Blaize Holdings, Inc.涨53.15%；中阳金融集团涨36.70%；Next Technology涨35.00%
03-25 15:04
美股夜盘 | Blaize Holdings, Inc.涨59.46%，Next Technology涨36.00%
Blaize Holdings, Inc.涨59.46%；Next Technology涨36.00%；NFT金融控股涨27.60%
03-25 13:03
美股夜盘 | Blaize Holdings, Inc.涨55.86%，Next Technology涨28.00%
Blaize Holdings, Inc.涨55.86%；Next Technology涨28.00%；Braze, Inc. Class A涨20.09%
03-25 10:04
美股夜盘 | Blaize Holdings, Inc.涨48.65%，Next Technology涨35.00%
Blaize Holdings, Inc.涨48.65%；Next Technology涨35.00%；Braze, Inc. Class A涨19.42%
03-25 09:04
Absci Q4 EPS $(0.20), Inline, Sales $650.000K Miss $1.100M Estimate
Absci (NASDAQ:ABSI) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.25) per share from the same period last year. The company
03-25 04:08
Absci targets Q4 2026 start for Phase 2 ABS-201 endometriosis trial
Absci targets Q4 2026 start for Phase 2 ABS-201 endometriosis trial Absci announced the launch of an endometriosis advisory board to guide the clinical research program for ABS-201, an anti-prolactin receptor antibody in clinical development for endometriosis. The company said it anticipates initiat
03-24 20:05
Earnings Scheduled For March 24, 2026
Companies Reporting Before The Bell • Fennec Pharmaceuticals (NASDAQ:FENC) is e...
03-24 19:11
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic
Absci Corporation launches an endometriosis advisory board for its ABS-201 program, a novel antibody targeting a non-hormonal pathway. The board includes leading experts from Yale, UCSF, and Mayo Clinic. ABS-201 aims to treat endometriosis without suppressing fertility, addressing an unmet need. The company plans to initiate Phase 2 trials in Q4 2026.
03-24 12:00
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
